Gainers
Trillium Therapeutics Inc. (NASDAQ: TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share, implying an equity value of $2.26 billion.
Gainers
Trillium Therapeutics Inc. (NASDAQ: TRIL) shares climbed 187.8% to $17.53 after the company agreed to be acquired by Pfizer for $18.50 per share, implying an equity value of $2.26 billion.
Landmark Infrastructure Partners LP ("Landmark," or the "Partnership") (NASDAQ:LMRK) today announced that, following lengthy negotiations between the Conflicts Committee of the Board of Directors of
Becker Boards, L.L.C. Managing Member Mark D. Becker issued the following letter:
August 11, 2021
VIA FEDEX
Mr. Steven Sonnestein
Chairman of the Board
Landmark Infrastructure Partners LP
400 Continental Blvd,